What is H.C. Wainwright's price target for FULC?

H.C. Wainwright's latest stated price target for Fulcrum Therapeutics Inc. (FULC) is $3, from its action on Jun 2, 2026.

What is H.C. Wainwright's rating on FULC?

H.C. Wainwright rates FULC Neutral, a neutral rating, as of Jun 2, 2026.

When did H.C. Wainwright last change its view on FULC?

On Jun 2, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $3.

Analyst firms · H.C. Wainwright · FULC

H.C. Wainwright FULC price target and rating history

Fulcrum Therapeutics Inc. (FULC) · Health Care

H.C. Wainwright rates Fulcrum Therapeutics Inc. (FULC) Neutral with a $3 price target, as of its latest action on Jun 2, 2026. It has published 6 rating actions on FULC since August 2021, including 2 upgrades and 3 downgrades. Across 5 firms with a FULC price target in the last 12 months, the median target is $3. H.C. Wainwright's target matches it.

Current rating: Neutral
Price target: $3
Median target, all firms: $3
Actions on FULC: 6

H.C. Wainwright price target on FULC

H.C. Wainwright price target on FULC, each point a stated target, August 2021 to June 2026. Targets before March 2023 (divided by 2) are adjusted for a stock split, going by the prior target H.C. Wainwright restated.

Every H.C. Wainwright rating on FULC

Jun 2, 2026
DowngradeH.C. Wainwright downgrades to Neutral from Buy, price target $3
Jul 29, 2025
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $4 to $12
Sep 13, 2024
DowngradeH.C. Wainwright downgrades to Neutral from Buy, price target $17 to $4
Aug 23, 2023
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $5 to $14
Mar 10, 2023
DowngradeH.C. Wainwright downgrades to Neutral from Buy, price target $20 to $6
Aug 17, 2021
ReiterateH.C. Wainwright raises its price target to $40 from $20, keeps Buy

How other firms rate FULC

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Piper Sandler	Neutral	$3	Jun 2, 2026
H.C. Wainwright	Neutral	$3	Jun 2, 2026
Leerink Partners	Market Perform	$4	Jun 2, 2026
Truist Securities	Hold	$4	Jun 2, 2026
Stifel	Hold	$3	Jun 2, 2026

Questions about H.C. Wainwright and FULC

What is H.C. Wainwright's price target for FULC?: H.C. Wainwright's latest stated price target for Fulcrum Therapeutics Inc. (FULC) is $3, from its action on Jun 2, 2026.
What is H.C. Wainwright's rating on FULC?: H.C. Wainwright rates FULC Neutral, a neutral rating, as of Jun 2, 2026.
When did H.C. Wainwright last change its view on FULC?: On Jun 2, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $3.
How does H.C. Wainwright's FULC target compare with other analysts?: Across 5 firms with a FULC price target in the last 12 months, the median target is $3. H.C. Wainwright's target matches it.

More FULC rating histories

All H.C. Wainwright ratings FULC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.